Treatment of dilatation of the ascending aorta: Bicuspid versus tricuspid aortic valve pathologies

被引：2

作者：

Girdauskas E. ^{[1
]}

von Kodolitsch Y. ^{[1
]}

Detter C. ^{[1
]}

Reichenspurner H. ^{[1
]}

机构：

[1] Universitäres Herzzentrum Hamburg, Martinistr. 52, Hamburg

来源：

Zeitschrift für Herz-,Thorax- und Gefäßchirurgie | 2017年 / 31卷 / 1期

关键词：

Bicuspid aortic valve; Biomarkers; Diameter; Heart valve diseases; Transvalvular blood flow;

D O I：

10.1007/s00398-016-0097-y

中图分类号：

学科分类号：

摘要：

Background: The development of individualized treatment concepts necessitates better risk prediction models for adverse aortic events and patient-tailored treatment strategies for dilatation of the ascending aorta. Objectives: This article provides an overview of traditional and modern markers for risk prediction of adverse aortic events and the state of the art evidence for specific treatment concepts of bicuspid versus tricuspid valve aortopathies. Material and methods: A systematic analysis of the current literature was carried out taking into account the implementation of modern biomarkers for risk prediction of adverse aortic events and differentiated treatment concepts for bicuspid versus tricuspid valve aortopathies. Results: The maximum cross-sectional aortic diameter alone is insufficient to provide reliable information for risk stratification with respect to the aortopathy, especially considering the heterogeneous nature of ascending aortic disease. The current literature indicates the presence of marked heterogeneity in the symptoms of diseases of the bicuspid aortic valve, which have different origins and a different prognosis and can therefore necessitate a specialized form of treatment. Based on the study results from recent years there are clear parallels between bicuspid and tricuspid valve aortopathies which, however, have not yet been investigated in prospective studies. Conclusion: The individualized risk analysis and therapy decision-making process for dilatation of the ascending aorta necessitate the future establishment of prognosis-based biomarkers in combination with traditional risk factors. © 2016, Springer-Verlag Berlin Heidelberg.

引用

页码：7 / 15

页数：8

共 30 条

[1]

Hagan P.G., Nienaber C.A., Isselbacher E.M., Bruckman D., Karavite D.J., Russman P.L., Evangelista A., Fattori R., Suzuki T., Oh J.K., Moore A.G., Malouf J.F., Pape L.A., Gaca C., Sechtem U., Lenferink S., Deutsch H.J., Diedrichs H., Marcos y Robles J., Llovet A., Gilon D., Das S.K., Armstrong W.F., Deeb G.M., Eagle K.A., The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease, JAMA, 283, pp. 897-903, (2000)

[2]

Yiu R.S., Cheng S.W., Natural history and risk factors for rupture of thoracic aortic arch aneurysms, J Vasc Surg, (2016)

[3]

Davies R.R., Goldstein L.J., Coady M.A., Tittle S.L., Rizzo J.A., Kopf G.S., Elefteriades J.A., Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size, Ann Thorac Surg, 73, pp. 17-27, (2002)

[4]

Davies R.R., Gallo A., Coady M.A., Tellides G., Botta D.M., Burke B., Coe M.P., Kopf G.S., Elefteriades J.A., Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms, Ann Thorac Surg, 81, pp. 169-177, (2006)

[5]

Della Corte A., Bancone C., Dialetto G., Covino F.E., Manduca S., Montibello M.V., De Feo M., Buonocore M., Nappi G., The ascending aorta with bicuspid aortic valve: a phenotypic classification with potential prognostic significance, Eur J Cardiothorac Surg, 46, pp. 240-247, (2014)

[6]

Nistri S., Grande-Allen J., Noale M., Basso C., Siviero P., Maggi S., Crepaldi G., Thiene G., Aortic elasticity and size in bicuspid aortic valve syndrome, Eur Heart J, 29, pp. 472-479, (2008)

[7]

Hiratzka L.F., Bakris G.L., Beckman J.A., Bersin R.M., Carr V.F., Casey D.E., Eagle K.A., Hermann L.K., Isselbacher E.M., Kazerooni E.A., Kouchoukos N.T., Lytle B.W., Milewicz D.M., Reich D.L., Sen S., Shinn J.A., Svensson L.G., Williams D.M., 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease, Circulation, 121, pp. e266-e369, (2010)

[8]

Erbel R., Aboyans V., Boileau C., Bossone E., Bartolomeo R.D., Eggebrecht H., Evangelista A., Falk V., Frank H., Gaemperli O., Grabenwoger M., Haverich A., Iung B., Manolis A.J., Meijboom F., Nienaber C.A., Roffi M., Rousseau H., Sechtem U., Sirnes P.A., Allmen R.S., Vrints C.J., 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatmen

[9]

Hiratzka L.F., Creager M.A., Isselbacher E.M., Svensson L.G., Nishimura R.A., Bonow R.O., Guyton R.A., Sundt T.M., Surgery for aortic dilatation in patients with bicuspid aortic valves: A statement of clarification from the American College of Cardiology/American Heart Association task force on clinical practice guidelines, J Am Coll Cardiol, 67, pp. 724-731, (2016)

[10]

Pape L.A., Tsai T.T., Isselbacher E.M., Oh J.K., O'gara P.T., Evangelista A., Fattori R., Meinhardt G., Trimarchi S., Bossone E., Suzuki T., Cooper J.V., Froehlich J.B., Nienaber C.A., Eagle K.A., Aortic diameter 〉or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD), Circulation, 116, pp. 1120-1127, (2007)

← 1 2 3 →